Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Policy Alerts

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 20 October 2006:
Vol. 314. no. 5798, p. 381
DOI: 10.1126/science.314.5798.381g

This Week in Science

Human immunodeficiency virus type-1 (HIV-1) is a retrovirus and uses reverse transcription to generate DNA, which enters the nucleus to integrate with the host DNA. The latter process is catalyzed by a virally-encoded integrase enzyme, and this latent reservoir represents a major obstacle to the treatment of HIV disease. The transcriptional coactivator LEDGF/p75 (p75) binds the HIV-1 integrase protein and protects it from degradation by the cell's proteasomal machinery. Llano et al. (p. 461, published online 7 September) now show that p75 plays a crucial role in viral integration by acting as tether between the integrase and chromatin. For the case of baculovirus replication, Goley et al. (p. 464) now find this process requires the redistribution of the actin cytoskeleton into the nucleus of infected cells. Autographa californica induces nuclear actin assembly by recruiting the host actin-nucleating Arp2/3 complex into the nucleus and activating it with p78/83, a Wiskott-Aldrich syndrome (WASP)-like viral protein. This unanticipated role for the assembly of actin in the nucleus may play a role in the action of other pathogens.






ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)